Skip to content

Key Factors of Leadless Pacemaker Implantation With Implantation Site, Complications and Prognosis

Relationship Between Key Factors of Leadless Pacemaker Implantation With Implantation Site, Intraoperative Complications and Prognosis

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05761821
Enrollment
300
Registered
2023-03-09
Start date
2022-10-01
Completion date
2024-12-31
Last updated
2023-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complication of Surgical Procedure, Pacemaker Complication, Pacemaker Syndrome

Keywords

leadless pacemaker, complication, Prognosis

Brief summary

To investigate the relationship between key variables in leadless pacemaker implantation with implantation site, intraoperative complications and prognosis.

Detailed description

In this study, we aim to include patients implated with leadless pacemakers, collect key variables and other clinical data during implantation of leadless pacemakers, and observe the final implantation site, intraoperative complications and prognosis information of patients. This study aims to clarify the relationship between key variables in leadless pacemaker implantation with implantation site, intraoperative complications and prognosis, and provide data support for the standardization of leadless pacemaker implantation process in China.

Interventions

All enrolled patients were implanted with leadless pacemaker.

Sponsors

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient received implantation of leadless pacemaker * Patient agreed to join into this study and signed informed consent

Exclusion criteria

* Age \< 18 years * Ventricular septal defect * History of mechanical tricuspid valve replacement * History of inferior vena cava filter placement * Pregnant or plan to be pregnant within 2 years * Life expectancy \< 1 year * Patient was included in other studies that could introduce bias into this study

Design outcomes

Primary

MeasureTime frameDescription
Serious adverse eventsDay 0 (Time of implantation)-Day 7including dislodgement (including detachment), cardiac perforation, pericardial effusion, and serious infection

Secondary

MeasureTime frameDescription
Device-related complicationsDay 0 (Time of implantation)-Day 7Femoral venipuncture site hematoma, hemorrhage, pseudoaneurysm, arteriovenous fistula, tricuspid valve injury
Serious adverse eventsDay 0 (Time of implantation)-Year 2including dislodgement (including detachment), cardiac perforation, pericardial effusion, and serious infection
Re-intervention of devicesDay 0 (Time of implantation)-Year 2extraction, re-implantation, or implantation of traditional transvenous pacemaker

Countries

China

Contacts

Primary ContactYangxin Chen, PhD
chenyx39@mail.sysu.edu.cn+8602081332360
Backup ContactQi Guo, MD
guoq69@mail.sysu.edu.cn+8602081332360

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026